Fabian, MR, Sonenberg, N. The mechanics of miRNA‐mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2 012, 19:586–593.
Treiber, T, Treiber, N, Meister, G. Regulation of microRNA biogenesis and function. Thromb Haemost 2012, 107:605–610.
Cullen, BR. Herpesvirus microRNAs: phenotypes and functions. Curr Opin Virol 2011, 1:211–215.
tenOever, BR. RNA viruses and the host microRNA machinery. Nat Rev Microbiol 2013, 11:169–180.
Whisnant, AW, Bogerd, HP, Flores, O, Ho, P, Powers, JG, Sharova, N, Stevenson, M, Chen, CH, Cullen, BR. In‐depth analysis of the interaction of HIV‐1 with cellular microRNA biogenesis and effector mechanisms. mBio 2013, 4:e000193.
Klase, Z, Houzet, L, Jeang, KT. MicroRNAs and HIV‐1: complex interactions. J Biol Chem 2012, 287:40884–40890.
Cullen, BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol 2013, 14:205–210.
Thibault, PA, Wilson, JA. Targeting miRNAs to treat hepatitis C virus infections and liver pathology: inhibiting the virus and altering the host. Pharmacol Res 2013. In Press.
Jopling, CL, Schutz, S, Sarnow, P. Position‐dependent function for a tandem microRNA miR‐122‐binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4:77–85.
Jopling, CL, Yi, M, Lancaster, AM, Lemon, SM, Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver‐specific MicroRNA. Science 2005, 309:1577–1581.
Li, Y, Masaki, T, Yamane, D, McGivern, DR, Lemon, SM. Competing and noncompeting activities of miR‐122 and the 5` exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A 2013, 110:1881–1886.
Roberts, AP, Lewis, AP, Jopling, CL. miR‐122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 2011, 39:7716–29.
Henke, JI, Goergen, D, Zheng, J, Song, Y, Schuttler, CG, Fehr, C, Junemann, C, Niepmann, M. microRNA‐122 stimulates translation of hepatitis C virus RNA. EMBO J 2008, 27:3300–3310.
Wilson, JA, Zhang, C, Huys, A, Richardson, CD. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol 2011, 85:2342–2350.
Jangra, RK, Yi, M, Lemon, SM. Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR‐122. J Virol 2010, 84:6615–6625.
Li, YP, Gottwein, JM, Scheel, TK, Jensen, TB, Bukh, J. MicroRNA‐122 antagonism against hepatitis C virus genotypes 1–6 and reduced efficacy by host RNA insertion or mutations in the HCV 5` UTR. Proc Natl Acad Sci U S A 2011, 108:4991–4996.
Lanford, RE, Hildebrandt‐Eriksen, ES, Petri, A, Persson, R, Lindow, M, Munk, ME, Kauppinen, S, Orum, H. Therapeutic silencing of microRNA‐122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198–201.
Janssen, HL, Reesink, HW, Lawitz, EJ, Zeuzem, S, Rodriguez‐Torres, M, Patel, K, van der Meer, AJ, Patick, AK, Chen, A, Zhou, Y, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013, 368:1685–1694.
Grimson, A, Farh, KK, Johnston, WK, Garrett‐Engele, P, Lim, LP, Bartel, DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 2007, 27:91–105.
Machlin, ES, Sarnow, P, Sagan, SM. Masking the 5` terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA‐target RNA complex. Proc Natl Acad Sci U S A 2011, 108:3193–3198.
Hon, LS, Zhang, Z. The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biol 2007, 8:R166.
Mortimer, SA, Doudna, JA. Unconventional miR‐122 binding stabilizes the HCV genome by forming a trimolecular RNA structure. Nucleic Acids Res 2013, 41:4230–4240.
Nasheri, N, Singaravelu, R, Goodmurphy, M, Lyn, RK, Pezacki, JP. Competing roles of microRNA‐122 recognition elements in hepatitis C virus RNA. Virology 2011, 410:336–344.
Shimakami, T, Yamane, D, Jangra, RK, Kempf, BJ, Spaniel, C, Barton, DJ, Lemon, SM. Stabilization of hepatitis C virus RNA by an Ago2‐miR‐122 complex. Proc Natl Acad Sci U S A 2012, 109:941–946.
Merino, EJ, Wilkinson, KA, Coughlan, JL, Weeks, KM. RNA structure analysis at single nucleotide resolution by selective 2`‐hydroxyl acylation and primer extension (SHAPE). J Am Chem Soc 2005, 127:4223–4231.
Pang, PS, Pham, EA, Elazar, M, Patel, SG, Eckart, MR, Glenn, JS. Structural map of a microRNA‐122: hepatitis C virus complex. J Virol 2012, 86:1250–1254.
Diaz‐Toledano, R, Ariza‐Mateos, A, Birk, A, Martinez‐Garcia, B, Gomez, J. In vitro characterization of a miR‐122‐sensitive double‐helical switch element in the 5` region of hepatitis C virus RNA. Nucleic Acids Res 2009, 37:5498–5510.
Goergen, D, Niepmann, M. Stimulation of Hepatitis C Virus RNA translation by microRNA‐122 occurs under different conditions in vivo and in vitro. Virus Res 2012, 167:343–352.
Thibault, PA, Huys, A, Dhillon, P, Wilson, JA. MicroRNA‐122‐dependent and ‐independent replication of Hepatitis C Virus in Hep3B human hepatoma cells. Virology 2013, 436:179–190.
Pillai, RS, Artus, CG, Filipowicz, W. Tethering of human Ago proteins to mRNA mimics the miRNA‐mediated repression of protein synthesis. RNA 2004, 10:1518–1525.
Randall, G, Panis, M, Cooper, JD, Tellinghuisen, TL, Sukhodolets, KE, Pfeffer, S, Landthaler, M, Landgraf, P, Kan, S, Lindenbach, BD, et al. Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 2007, 104:12884–12889.
Zhang, C, Huys, A, Thibault, PA, Wilson, JA. Requirements for human Dicer and TRBP in microRNA‐122 regulation of HCV translation and RNA abundance. Virology 2012, 433:479–488.
Conrad, KD, Giering, F, Erfurth, C, Neumann, A, Fehr, C, Meister, G, Niepmann, M. MicroRNA‐122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation. PLoS One 2013, 8:e56272.
Norman, KL, Sarnow, P. Modulation of hepatitis C virus RNA abundance and the isoprenoid biosynthesis pathway by microRNA miR‐122 involves distinct mechanisms. J Virol 2010, 84:666–670.
Villanueva, RA, Jangra, RK, Yi, M, Pyles, R, Bourne, N, Lemon, SM. miR‐122 does not modulate the elongation phase of hepatitis C virus RNA synthesis in isolated replicase complexes. Antiviral Res 2010, 88:119–123.
Zhu, Q, Guo, JT, Seeger, C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J Virol 2003, 77:9204–9210.
Ali, S, Pellerin, C, Lamarre, D, Kukolj, G. Hepatitis C virus subgenomic replicons in the human embryonic kidney 293 cell line. J Virol 2004, 78:491–501.
Kato, T, Date, T, Miyamoto, M, Zhao, Z, Mizokami, M, Wakita, T. Nonhepatic cell lines HeLa and 293 support efficient replication of the hepatitis C virus genotype 2a subgenomic replicon. J Virol 2005, 79:592–596.
Date, T, Kato, T, Miyamoto, M, Zhao, Z, Yasui, K, Mizokami, M, Wakita, T. Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY‐N9 cells. J Biol Chem 2004, 279:22371–22376.
Narbus, CM, Israelow, B, Sourisseau, M, Michta, ML, Hopcraft, SE, Zeiner, GM, Evans, MJ. HepG2 cells expressing microRNA miR‐122 support the entire hepatitis C virus life cycle. J Virol 2011, 85:12087–12092.
Sagan, SM, Sarnow, P, Wilson, JA. Modulation of GB virus B RNA abundance by microRNA‐122: dependence on and escape from microRNA‐122 restriction. J Virol 2013, 87:7338–7347.
De Tomassi, A, Pizzuti, M, Traboni, C. Hep3B human hepatoma cells support replication of the wild‐type and a 5`‐end deletion mutant GB virus B replicon. J Virol 2003, 77:11875–11881.
Kambara, H, Fukuhara, T, Shiokawa, M, Ono, C, Ohara, Y, Kamitani, W, Matsuura, Y. Establishment of a novel permissive cell line for the propagation of hepatitis C virus by expression of microRNA miR122. J Virol 2012, 86:1382–1393.
Lin, LT, Noyce, RS, Pham, TN, Wilson, JA, Sisson, GR, Michalak, TI, Mossman, KL, Richardson, CD. Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor 3 and expression of liver‐specific microRNA 122. J Virol 2010, 84:9170–9180.
Chang, J, Guo, JT, Jiang, D, Guo, H, Taylor, JM, Block, TM. Liver‐specific microRNA miR‐122 enhances the replication of hepatitis C virus in nonhepatic cells. J Virol 2008, 82:8215–8223.
Fukuhara, T, Kambara, H, Shiokawa, M, Ono, C, Katoh, H, Morita, E, Okuzaki, D, Maehara, Y, Koike, K, Matsuura, Y. Expression of microRNA miR‐122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J Virol 2012, 86:7918–7933.
Da Costa, D, Turek, M, Felmlee, DJ, Girardi, E, Pfeffer, S, Long, G, Bartenschlager, R, Zeisel, MB, Baumert, TF. Reconstitution of the entire hepatitis C virus life cycle in nonhepatic cells. J Virol 2012, 86:11919–11925.
Wu, X, Robotham, JM, Lee, E, Dalton, S, Kneteman, NM, Gilbert, DM, Tang, H. Productive hepatitis C virus infection of stem cell‐derived hepatocytes reveals a critical transition to viral permissiveness during differentiation. PLoS Pathog 2012, 8:e1002617.
Parker, R, Sheth, U. P bodies and the control of mRNA translation and degradation. Mol Cell 2007, 25:635–646.
Ariumi, Y, Kuroki, M, Kushima, Y, Osugi, K, Hijikata, M, Maki, M, Ikeda, M, Kato, N. Hepatitis C virus hijacks P‐body and stress granule components around lipid droplets. J Virol 2011, 85:6882–6892.
Pager, CT, Schutz, S, Abraham, TM, Luo, G, Sarnow, P. Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules. Virology 2013, 435:472–484.
Scheller, N, Mina, LB, Galao, RP, Chari, A, Gimenez‐Barcons, M, Noueiry, A, Fischer, U, Meyerhans, A, Diez, J. Translation and replication of hepatitis C virus genomic RNA depends on ancient cellular proteins that control mRNA fates. Proc Natl Acad Sci U S A 2009, 106:13517–13522.
Huys, A, Thibault, PA, Wilson, JA. Modulation of Hepatitis C Virus RNA accumulation and translation by DDX6 and miR‐122 are mediated by separate mechanisms. PLoS One 2013, 8:e67437.
Chahar, HS, Chen, S, Manjunath, N. P‐body components LSM1, GW182, DDX3, DDX6 and XRN1 are recruited to WNV replication sites and positively regulate viral replication. Virology 2013, 436:1–7.
Ward, AM, Bidet, K, Yinglin, A, Ler, SG, Hogue, K, Blackstock, W, Gunaratne, J, Garcia‐Blanco, MA. Quantitative mass spectrometry of DENV‐2 RNA‐interacting proteins reveals that the DEAD‐box RNA helicase DDX6 binds the DB1 and DB2 3` UTR structures. RNA Biol 2011, 8:1173–1186.
Burbelo, PD, Dubovi, EJ, Simmonds, P, Medina, JL, Henriquez, JA, Mishra, N, Wagner, J, Tokarz, R, Cullen, JM, Iadarola, MJ, et al. Serology‐enabled discovery of genetically diverse hepaciviruses in a new host. J Virol 2012, 86:6171–6178.
Kapoor, A, Simmonds, P, Gerold, G, Qaisar, N, Jain, K, Henriquez, JA, Firth, C, Hirschberg, DL, Rice, CM, Shields, S, et al. Characterization of a canine homolog of hepatitis C virus. Proc Natl Acad Sci U S A 2011, 108:11608–11613.
Lyons, S, Kapoor, A, Sharp, C, Schneider, BS, Wolfe, ND, Culshaw, G, Corcoran, B, McGorum, BC, Simmonds, P. Nonprimate hepaciviruses in domestic horses, United kingdom. Emerg Infect Dis 2012, 18:1976–1982.
Kapoor, A, Simmonds, P, Scheel, TK, Hjelle, B, Cullen, JM, Burbelo, PD, Chauhan, LV, Duraisamy, R, Sanchez Leon, M, Jain, K, et al. Identification of rodent homologs of hepatitis C virus and pegiviruses. mBio 2013, 4:e00216–e00313.
Morita, K, Taketomi, A, Shirabe, K, Umeda, K, Kayashima, H, Ninomiya, M, Uchiyama, H, Soejima, Y, Maehara, Y. Clinical significance and potential of hepatic microRNA‐122 expression in hepatitis C. Liver Int 2011, 31:474–484.
Jangra, RK, Yi, M, Lemon, SM. DDX6 (Rck/p54) is required for efficient hepatitis C virus replication but not for internal ribosome entry site‐directed translation. J Virol 2010, 84:6810–6824.
Sarasin‐Filipowicz, M, Krol, J, Markiewicz, I, Heim, MH, Filipowicz, W. Decreased levels of microRNA miR‐122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009, 15:31–33.